Published in Clin Biochem on May 06, 2008
Identification of microRNAs associated with ileal and colonic Crohn's disease. Inflamm Bowel Dis (2010) 1.89
Biomarkers in inflammatory bowel disease: current practices and recent advances. Transl Res (2012) 1.29
New serological biomarkers of inflammatory bowel disease. World J Gastroenterol (2008) 1.06
Proteomic profiling of mucosal and submucosal colonic tissues yields protein signatures that differentiate the inflammatory colitides. Inflamm Bowel Dis (2010) 1.06
Applications of proteomics in the study of inflammatory bowel diseases: Current status and future directions with available technologies. Inflamm Bowel Dis (2009) 1.05
Challenges for biomarker discovery in body fluids using SELDI-TOF-MS. J Biomed Biotechnol (2009) 1.05
Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis. Ann Rheum Dis (2008) 0.99
Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies. World J Gastroenterol (2014) 0.93
Dysregulation of anti-inflammatory annexin A1 expression in progressive Crohns Disease. PLoS One (2013) 0.82
Current advantages in the application of proteomics in inflammatory bowel disease. Dig Dis Sci (2012) 0.82
Current application of proteomics in biomarker discovery for inflammatory bowel disease. World J Gastrointest Pathophysiol (2016) 0.81
Serum Proteome Profiles in Stricturing Crohn's Disease: A Pilot Study. Inflamm Bowel Dis (2015) 0.80
Serum protein profiling of adults and children with Crohn disease. J Pediatr Gastroenterol Nutr (2015) 0.76
Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized Medicine. Inflamm Bowel Dis (2015) 0.76
New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes. Inflamm Bowel Dis (2016) 0.75
Identification of Candidate Genes Related to Inflammatory Bowel Disease Using Minimum Redundancy Maximum Relevance, Incremental Feature Selection, and the Shortest-Path Approach. Biomed Res Int (2017) 0.75
Genomics and proteomics: Applications in autoimmune diseases. Pharmgenomics Pers Med (2009) 0.75
Update on current applications of proteomic in the study of inflammatory bowel disease. Ann Gastroenterol (2012) 0.75
The IBD interactome: an integrated view of aetiology, pathogenesis and therapy. Nat Rev Gastroenterol Hepatol (2017) 0.75
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet (2008) 30.20
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 16.13
Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet (2007) 8.63
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet (2002) 5.31
Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci (2005) 5.01
Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Crit Care Med (2012) 4.76
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohns Colitis (2010) 3.97
Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet (2009) 3.82
Elongator controls the migration and differentiation of cortical neurons through acetylation of alpha-tubulin. Cell (2009) 3.80
Inferring regulatory networks from expression data using tree-based methods. PLoS One (2010) 3.37
Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease. Nat Genet (2010) 3.22
Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat Genet (2008) 2.67
Development of the Crohn's disease digestive damage score, the Lémann score. Inflamm Bowel Dis (2010) 2.20
An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Hum Mol Genet (2007) 2.14
Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated? Trends Biochem Sci (2008) 2.08
Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia. Mol Cell (2006) 2.02
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment. Arthritis Res Ther (2005) 1.96
Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection. Inflamm Bowel Dis (2007) 1.85
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial. Ann Rheum Dis (2007) 1.83
Fibrin glue is effective healing perianal fistulas in patients with Crohn's disease. Gastroenterology (2010) 1.73
NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene (2003) 1.71
Management of inflammatory bowel disease in pregnancy. J Crohns Colitis (2012) 1.69
Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology (2002) 1.55
H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy. Gut (2011) 1.52
Proteomic mass spectra classification using decision tree based ensemble methods. Bioinformatics (2005) 1.52
Cystatin C blood level as a risk factor for death after heart surgery. Eur Heart J (2007) 1.48
Predictors of severe Crohn's disease. Scand J Gastroenterol (2008) 1.47
Random subwindows and extremely randomized trees for image classification in cell biology. BMC Cell Biol (2007) 1.47
Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3. J Biol Chem (2003) 1.47
Natalizumab to kill two birds with one stone: a case of celiac disease and multiple sclerosis. Inflamm Bowel Dis (2011) 1.42
GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity. Mol Cell (2004) 1.42
Is cystatin C useful for the detection and the estimation of low glomerular filtration rate in heart transplant patients? Transplantation (2007) 1.41
In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas. Clin Cancer Res (2004) 1.40
Measurement uncertainty of creatinine in low values: Another good reason not to use the MDRD formula with low creatinine values. Clin Biochem (2006) 1.38
Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease. Am J Gastroenterol (2002) 1.32
Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects. J Crohns Colitis (2010) 1.32
MicroRNAs profiling in murine models of acute and chronic asthma: a relationship with mRNAs targets. PLoS One (2011) 1.31
Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKepsilon-dependent Lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF. J Biol Chem (2007) 1.30
PREDetector: a new tool to identify regulatory elements in bacterial genomes. Biochem Biophys Res Commun (2007) 1.27
Characterization of bacteria in biopsies of colon and stools by high throughput sequencing of the V2 region of bacterial 16S rRNA gene in human. PLoS One (2011) 1.25
A screening methodology based on Random Forests to improve the detection of gene-gene interactions. Eur J Hum Genet (2010) 1.20
Optimising monitoring in the management of Crohn's disease: a physician's perspective. J Crohns Colitis (2013) 1.20
NOD2/CARD15 does not influence response to infliximab in Crohn's disease. Gastroenterology (2002) 1.20
A new tool in the field of in-vitro diagnosis of allergy: preliminary results in the comparison of ImmunoCAP© 250 with the ImmunoCAP© ISAC. Clin Chem Lab Med (2010) 1.19
Noninvasive assessment of Crohn's disease intestinal lesions with (18)F-FDG PET/CT. J Nucl Med (2007) 1.18
Supervised learning with decision tree-based methods in computational and systems biology. Mol Biosyst (2009) 1.18
Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy. Inflamm Bowel Dis (2013) 1.17
Interleukin-6: An osteotropic factor influencing bone formation? Bone (2005) 1.17
Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy. Clin Gastroenterol Hepatol (2010) 1.15
Automated processing of zebrafish imaging data: a survey. Zebrafish (2013) 1.14
Plasmatic cystatin C for the estimation of glomerular filtration rate in intensive care units. Intensive Care Med (2004) 1.11
Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling. Biochem Pharmacol (2006) 1.10
Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology (Oxford) (2010) 1.10
Guillain-Barré syndrome following hepatitis E. World J Gastroenterol (2009) 1.10
Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis Rheum (2005) 1.08
Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn's disease with normal C-reactive protein serum level. Inflamm Bowel Dis (2007) 1.08
The emerging role of lysine acetylation of non-nuclear proteins. Cell Mol Life Sci (2010) 1.07
De novo C16- and C24-ceramide generation contributes to spontaneous neutrophil apoptosis. J Leukoc Biol (2007) 1.07
NF-kappaB-dependent MnSOD expression protects adenocarcinoma cells from TNF-alpha-induced apoptosis. Oncogene (2002) 1.07
P2X1 ion channels promote neutrophil chemotaxis through Rho kinase activation. J Immunol (2009) 1.05
Challenges for biomarker discovery in body fluids using SELDI-TOF-MS. J Biomed Biotechnol (2009) 1.05